These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 16006772)
21. The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery. Slotwiński R; Olszewski WL; Chaber A; Slodkowski M; Zaleska M; Krasnodebski IW J Clin Immunol; 2002 Sep; 22(5):289-96. PubMed ID: 12405162 [TBL] [Abstract][Full Text] [Related]
22. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Hasegawa Y; Sawada M; Ozaki N; Inagaki T; Suzumura A Gerontology; 2000; 46(4):185-8. PubMed ID: 10859456 [TBL] [Abstract][Full Text] [Related]
23. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels. Pollmächer T; Korth C; Schreiber W; Hermann D; Mullington J Cytokine; 1996 Oct; 8(10):799-803. PubMed ID: 8980882 [TBL] [Abstract][Full Text] [Related]
24. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312 [TBL] [Abstract][Full Text] [Related]
25. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183 [TBL] [Abstract][Full Text] [Related]
26. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. Sato N; Koeda K; Kimura Y; Ikeda K; Ogawa M; Saito K; Endo S Eur Surg Res; 2001; 33(4):279-84. PubMed ID: 11684834 [TBL] [Abstract][Full Text] [Related]
27. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis]. Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355 [TBL] [Abstract][Full Text] [Related]
28. Circulating levels of soluble CD30 and other markers in colorectal cancer patients. Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247 [TBL] [Abstract][Full Text] [Related]
29. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer. Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929 [TBL] [Abstract][Full Text] [Related]
30. Hematopoietic growth factors in colorectal cancer patients. Mroczko B; Szmitkowski M; Okulczyk B Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262 [TBL] [Abstract][Full Text] [Related]
31. [Cytokines and soluble cytokine receptors in the perioperative period]. Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152 [TBL] [Abstract][Full Text] [Related]
32. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps. Johdi NA; Mazlan L; Sagap I; Jamal R Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023 [TBL] [Abstract][Full Text] [Related]
33. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887 [TBL] [Abstract][Full Text] [Related]
34. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients. Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255 [TBL] [Abstract][Full Text] [Related]
35. Hematopoietic cytokines in the sera of patients with pancreatic cancer. Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207 [TBL] [Abstract][Full Text] [Related]
36. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients. Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345 [TBL] [Abstract][Full Text] [Related]
37. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients. Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379 [TBL] [Abstract][Full Text] [Related]
38. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Wang XS; Williams LA; Krishnan S; Liao Z; Liu P; Mao L; Shi Q; Mobley GM; Woodruff JF; Cleeland CS Brain Behav Immun; 2012 Jul; 26(5):699-705. PubMed ID: 22251605 [TBL] [Abstract][Full Text] [Related]
39. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Petretta M; Condorelli GL; Spinelli L; Scopacasa F; de Caterina M; Leosco D; Vicario ML; Bonaduce D Am Heart J; 2000 Dec; 140(6):E28. PubMed ID: 11100001 [TBL] [Abstract][Full Text] [Related]
40. Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people. Komosinska-Vassev K; Olczyk P; Winsz-Szczotka K; Klimek K; Olczyk K Clin Chem Lab Med; 2011 Jan; 49(1):121-7. PubMed ID: 20961189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]